Prof. Dr. Kayser ÇAĞLAR
Nefroloji ve İç Hastalıkları Uzmanı
Web Sitesi: 

Görev Aldığı Lokasyonlar
Memorial Ankara Hastanesi

Görev Aldığı Tıbbi Birimler
İç Hastalıkları
Nefroloji

Doğum Yeri, Tarihi
Tunceli / Türkiye , 1964

Yabancı Diller
İngilizce

E-mail Adresi
kaysercaglar@memorial.com.tr

Telefon Numarası
444 7 888

Deneyim
MEMORIAL ANKARA HASTANESİ

Nefroloji ve İç Hastalıkları Uzmanı
2013 - Halen, Ankara/Türkiye

Vanderbilt University Medical Center

Nefroloji Bölümü
2000 - 2001, ABD

Gülhane Askeri Tıp Akademisi

Nefroloji Bilim Dalı
1997 - 2013, Ankara/Türkiye

Ağrı Asker Hastanesi

İç Hastalıkları Uzmanı
1995 - 1997, Ağrı/Türkiye

Eğitim
PROFESÖR

-
2009 , Ankara/Türkiye

DOÇENT

-
2003 - 2009 , Ankara/Türkiye

GATA NEFROLOJİ BİLİM DALI

Nefroloji Yandal Uzmanlık Eğitimi
1995 - 1997 , Ankara/Türkiye

GATA İÇ HASTALIKLARI ANA BİLİM DALI

İç Hastalıkları Uzmanlık Eğitimi
1989 - 1993 , Ankara/Türkiye

GATA TIP FAKÜLTESİ

Tıp Doktoru Eğitimi
1980 - 1986 , Ankara/Türkiye

Bilimsel Yayınları
Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E, Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A. Red Cell Distribution Width Is Independently Related to Endothelial Dysfunction in Patients With Chronic Kidney Disease.
Am J Med Sci. 2013 Aug 7.
Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M. Mean Corpuscular Volume is Associated with Endothelial Dysfunction and Predicts Composite Cardiovascular Events in Patients with Chronic Kidney Disease.
Nephrology (Carlton). 2013 Jul 12, doi: 10.1111/nep.12130
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C. Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation.
Am J Nephrol. 2013;37(2):126-34.
Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.
Clin Exp Nephrol. 2013 Aug;17(4):532-40.
Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum uric acid independently predicts cardiovascular events in advanced nephropathy.
Am J Nephrol. 2012;36(4):324-31.
Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
Am J Nephrol. 2012;36(3):228-37.
M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU, Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?
Int Urol Nephrol. 2013 Feb;45(1):151-6.
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Am J Kidney Dis. 2012 Feb;59(2):177-85.
Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.
Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25.
Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes.
Nephrol Dial Transplant. 2011 Nov;26(11):3537-43.
Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92.
Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease.
Am J Nephrol. 2011;33(1):25-32.
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.
Kidney Int. 2010 Oct;78(7):679-85.
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Cayci T, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Axelsson J. Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
Nephrol Dial Transplant. 2010 Oct;25(10):3250-6.
Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu M, Yilmaz MI. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
Nephrology (Carlton). 2010 Mar;15(2):225-9.
Sonmez A, Yilmaz MI, Saglam M, Kilic S, Eyileten T, Uckaya G, Caglar K, Oguz Y, Vural A, Yenicesu M, Kutlu M, Kinalp C, Zoccali C. The relationship between hemoglobin levels and endothelial functions in diabetes mellitus.
Clin J Am Soc Nephrol. 2010 Jan;5(1):45-50.
Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Low Triiodothyronine Alters Flow-Mediated Vasodilatation in Advanced Nondiabetic Kidney Disease.
Am J Nephrol. 2010 Dec 9;33(1):25-32.
Afsar B, Afsar RE, Sen ST, Kirkpantur A, Eyileten T, Yilmaz MI, Caglar K. Simple renal cysts and circadian blood pressure: are they related to each other in patients with hypertension?
Int Urol Nephrol. 2010 Apr 13.
Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease.
Am J Nephrol. 2010;31(3):214-21.
Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Oguz Y, Aslan I, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
Clin Transplant. 2009 Mar-Apr;23(2):241-8.
Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K, Kirkpantur A, Celik T, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
Clin J Am Soc Nephrol. 2009 Mar;4(3):535-41.
Yilmaz MI, Sonmez A, Saglam M, Gulec M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease.
Kidney Int. 2009 Jun;75(12):1316-21.
Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C, Yenicesu M, Vural A. The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria.
Ren Fail. 2009;31(1):29-35.
Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A, Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
Nephrol Dial Transplant. 2008 May;23(5):1621-7
Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Nephrol Dial Transplant. 2008 Mar;23(3):959-65.
Beyzadeoglu M, Arpaci F, Surenkok S, Ozyigit G, Oysul K, Caglar K, Ataergin S, Yenicesu M, Kaya A. Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Saudi Med J. 2008 Jun;29(6):832-6.
Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Sonmez A, Eyileten T, Yenicesu M, Oguz Y, Tasar M, Vural A, Ikizler TA, Stenvinkel P, Lindholm B. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease.
Nephron Clin Pract. 2008;108(3):c233-40.
Yilmaz MI, Sonmez A, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Cakir E, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.
J Am Soc Nephrol. 2008 Feb;19(2):388-95.
Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A, Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
Nephrol Dial Transplant. 2008 May;23(5):1621-7.
Sonmez A, Yilmaz MI, Korkmaz A, Topal T, Caglar K, Kaya A, Eyileten T, Yenicesu M, Oguz Y, Basal S, Ipcioglu OM, Vural A. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Clin Exp Nephrol. 2008 Apr;12(2):110-8.
Caglar K , Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Clin J Am Soc Nephrol. 2008 Jan;3(1):61-8.
Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Nephrol Dial Transplant. 2008 Mar;23(3):959-65.
Kara B, Caglar K, Kilic S. Nonadherence with diet and fluid restrictions and perceived social support in patients receiving hemodialysis.
J Nurs Scholarsh. 2007;39(3):243-8.
Yilmaz MI, Saglam M, Sonmez A, Caglar K, Cakir E, Kurt Y, Eyileten T, Tasar M, Acikel C, Oguz Y, Vural A, Yenicesu M. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
Blood Purif. 2007;25(4):327-35.
Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Nephrology (Carlton). 2007 Apr;12(2):147-53.
Caglar K , Yilmaz MI, Saglam M, Cakir E, Kilic S, Eyileten T, Sonmez A, Oguz Y, Oner K, Ors F, Vural A, Yenicesu M. Endothelial dysfunction and fetuin A levels before and after kidney transplantation.
Transplantation. 2007 Feb 27;83(4):392-7.
Caglar K , Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.
Kidney Int. 2006 Aug;70(4):781-7.
Oguz Y, Yilmaz MI, Eyileten T, Caglar K, Yenicesu M, Kaya A, Tasar M, Saglam M, Doganci L, Gulec B, Oner K, Oktenli C, Vural A. Persistent mediastinal and axillary lymph node tuberculosis in a renal transplant patient with successful outcome.
Transplant Proc. 2006 Jun;38(5):1336-40.
Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K. Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases.
Int J Hematol. 2006 Apr;83(3):254-8.
Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T, Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model. Nephron Exp Nephrol. 2006;104(1):e15-22.
Yilmaz MI, Saglam M, Caglar K, Cakir E, Ozgurtas T, Sonmez A, Eyileten T, Yenicesu M, Acikel C, Oguz Y, Ozcan O, Bozlar U, Erbil K, Aslan I, Vural A. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation. 2005 Dec 27;80(12):1660-6.
Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Am J Kidney Dis. 2006 Jan;47(1):42-50.
Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Kir T, Acikel C, Bingol N, Oguz Y, Ikizler TA, Vural A. Adiponectin level is reduced and inversely correlated with the degree of proteinuria in type 2 diabetic patients.
Clin Nephrol. 2005 Jul;64(1):12-9.
Vural A, Yilmaz MI, Caglar K, Aydin A, Sonmez A, Eyileten T, Acikel C, Gulec B, Kozak O, Oner K. Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens.
Am J Nephrol. 2005 May-Jun;25(3):250-5.
Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology. 2005 Jun;65(6):1168-72
Yilmaz MI, Sonmez A, Caglar K, Gok DE, Eyileten T, Yenicesu M, Acikel C, Bingol N, Kilic S, Oguz Y, Vural A. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.
Endocrine. 2004 Dec;25(3):207-14.
Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S, Bingol N, Bingol S, Vural A. Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria.
Nephron Clin Pract. 2005;99(4):c115-21.
Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA. Uremic malnutrition is a predictor of death independent of inflammatory status.
Kidney Int. 2004 Nov;66(5):2054-60.
Demirkiliç U, Kuralay E, Yenicesu M, Caglar K, Oz BS, Cingöz F, Günay C, Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H. Timing of replacement therapy for acute renal failure after cardiac surgery.
J Card Surg. 2004 Jan-Feb;19(1):17-20.
Caglar K, Odabasi Z, Safali M, Yenicesu M, Vural A. Colchicine-induced myopathy with myotonia in a patient with chronic renal failure.
Clin Neurol Neurosurg. 2003 Sep;105(4):274-6.
Caglar K, Hakim RM, Ikizler TA.Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
Nutr Rev. 2002 Nov;60(11):378-87. Review.
Caglar K, Kinalp C, Arpaci F, Turan M, Saglam K, Ozturk B, Komurcu S, Yavuz I, Yenicesu M, Ozet A, Vural A. Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation.
Nephrol Dial Transplant. 2002 Nov;17(11):1931-5.
Caglar K, Safali M, Yavuz I, Odabaşi Z, Yenicesu M, Vural A. Colchicine-induced myopathy with normal creatine phosphokinase level in a renal transplant patient.
Nephron. 2002 Dec;92(4):922-4.
Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA. Inflammatory signals associated with hemodialysis.
Kidney Int. 2002 Oct;62(4):1408-16.
Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic effects of oral nutritional supplementation during hemodialysis.
Kidney Int. 2002 Sep;62(3):1054-9.
Pupim LB, Kent P, Caglar K, Shyr Y, Hakim RM, Ikizler TA. Improvement in nutritional parameters after initiation of chronic hemodialysis.
Am J Kidney Dis. 2002 Jul;40(1):143-51.
Caglar K, Orhan ME, Gulec B, Yavuz I, Yenicesu M, Guzeldemir E, Vural A. Severe rhabdomyolysis due to malignant hyperthermia during renal transplantation procedure can cause delayed graft function.
Am J Nephrol. 2002 Jan-Feb;22(1):81-3.
Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural A, Ozdemir IC. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
J Clin Endocrinol Metab. 2002 Feb;87(2):853-8.
Caglar K, Kibar Y, Tahmaz L, Safali M. Laser therapy in patient with intractable haemorrhage due to the bladder involvement of systemic amyloidosis.
Nephrol Dial Transplant. 2001 Aug;16(8):1724.
Caglar K, Kibar Y, Tahmaz L, Tekin A, Yenicesu M, Vural A. Polycystic horseshoe kidney.
Clin Nephrol. 2001 Jun;55(6):487-8.
Dinc A, Simsek I, Pay S, Caglar K, Can C. Fabry's disease mimicking familial Mediterranean fever.
Clin Exp Rheumatol. 2000 Nov-Dec;18(6):787-8.
Bulucu F, Vural A, Yenicesu M, Caglar K. Association of Gitelman's syndrome and focal glomerulosclerosis.
Nephron. 1998;79(2):244.
Vural A, Oguz Y, Oktenli C, Yenicesu M, Caglar K, Tanboga H. Detection of source of haematuria after extracorporeal shock wave lithotripsy (ESWL) by automated measurement of urinary red cell volume.
Int Urol Nephrol. 1998;30(1):31-7.

Mesleki Ödüller ve Dereceleri
37th Congress of the European Renal Association, European Dialysis and Transplantation Association (ERA-EDTA) kongresi bilimsel sunum ödülü (1999)
42th ERA-EDTA kongresi en iyi sözlü sunum ödülü (2005)
44th ERA-EDTA kongresi sözlü sunum ödülü (2007)

Mesleki Üyelikleri
Türk Nefroloji Derneği
Türk Hipertansiyon ve Böbrek Hastalıkları Derneği
ERA-EDTA üyeliği